Letko, Brosseau & Associates Inc Profound Medical Corp. Transaction History

Letko, Brosseau & Associates Inc

$4.6 Billion
Q1 2025

A detailed history of Letko, Brosseau & Associates Inc transactions in Profound Medical Corp. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 1,207,850 shares of PROF stock, worth $6.88 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,207,850

Previous 1,211,150 0.27%

Holding current value

$6.88 Million

Previous $9.1 Million 22.72%

% of portfolio

0.15%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$5.81 - $7.9 $19,173 - $26,070	-3,300 Reduced 0.27%	1,207,850 $7.03 Million
Q4 2024 Feb 14, 2025	BUY	$6.98 - $8.96 $86,377 - $110,880	12,375 Added 1.03%	1,211,150 $9.1 Million
Q2 2024 Aug 06, 2024	SELL	$7.25 - $9.07 $236,712 - $296,135	-32,650 Reduced 2.65%	1,198,775 $10.1 Million
Q1 2024 May 08, 2024	BUY	$7.3 - $9.46 $391,097 - $506,819	53,575 Added 4.55%	1,231,425 $10.5 Million
Q4 2023 Feb 12, 2024	BUY	$7.85 - $11.18 $107,741 - $153,445	13,725 Added 1.18%	1,177,850 $10 Million
Q3 2023 Nov 09, 2023	SELL	$7.91 - $13.27 $32,826 - $55,070	-4,150 Reduced 0.36%	1,164,125 $11.9 Million
Q2 2023 Aug 10, 2023	SELL	$9.27 - $14.88 $32,445 - $52,080	-3,500 Reduced 0.3%	1,168,275 $15.2 Million
Q1 2023 May 11, 2023	SELL	$8.85 - $13.27 $76,552 - $114,785	-8,650 Reduced 0.73%	1,171,775 $10.9 Million
Q4 2022 Feb 10, 2023	SELL	$3.18 - $10.91 $239,295 - $820,977	-75,250 Reduced 5.99%	1,180,425 $12.6 Million
Q3 2022 Nov 10, 2022	BUY	$3.99 - $9.3 $2,593 - $6,045	650 Added 0.05%	1,255,675 $5.01 Million
Q2 2022 Aug 09, 2022	SELL	$6.34 - $9.53 $279,594 - $420,273	-44,100 Reduced 3.39%	1,255,025 $8.89 Million
Q1 2022 May 11, 2022	BUY	$8.16 - $11.33 $3.89 Million - $5.4 Million	476,875 Added 58.0%	1,299,125 $11.7 Million
Q4 2021 Feb 09, 2022	BUY	$10.38 - $15.2 $44,374 - $64,980	4,275 Added 0.52%	822,250 $9.28 Million
Q3 2021 Nov 03, 2021	BUY	$13.6 - $17.88 $93,840 - $123,372	6,900 Added 0.85%	817,975 $11.9 Million
Q2 2021 Jul 29, 2021	SELL	$16.0 - $20.59 $141,200 - $181,706	-8,825 Reduced 1.08%	811,075 $13.2 Million
Q1 2021 May 11, 2021	SELL	$19.16 - $28.09 $379,368 - $556,182	-19,800 Reduced 2.36%	819,900 $16.4 Million
Q4 2020 Feb 05, 2021	BUY	$16.4 - $22.9 $13 Million - $18.2 Million	793,700 Added 1725.43%	839,700 $17.3 Million
Q3 2020 Nov 09, 2020	BUY	$14.05 - $18.13 $646,300 - $833,980	46,000 New	46,000 $811,000

Others Institutions Holding PROF

# of Institutions

Shares Held

13M

Call Options Held

3.3K

Put Options Held

9.3K

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $119M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Account

Letko, Brosseau & Associates Inc Profound Medical Corp. Transaction History